Top 5 Stocks to Buy Now
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free VECT Stock Alerts

VectivBio (VECT) Competitors

VectivBio logo
$16.85 0.00 (0.00%)
As of 06/18/2026
Compare

VECT vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy VectivBio stock or one of its competitors? MarketBeat compares VectivBio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VectivBio include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does VectivBio compare to Ainos?

Ainos (NASDAQ:AIMDW) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
VectivBioN/AN/AN/AN/AN/A

In the previous week, VectivBio had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Ainos. Ainos' average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.

Company Overall Sentiment
Ainos Neutral
VectivBio Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
VectivBio N/A N/A N/A

Summary

Ainos and VectivBio tied by winning 1 of the 2 factors compared between the two stocks.

How does VectivBio compare to Alvotech?

VectivBio (NASDAQ:VECT) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, VectivBio had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Alvotech. VectivBio's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Summary

VectivBio and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

How does VectivBio compare to Aravive?

Aravive (NASDAQ:ARAV) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

In the previous week, VectivBio had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
VectivBio Neutral

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
VectivBio N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
VectivBioN/AN/AN/AN/AN/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Comparatively, 9.7% of VectivBio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Aravive beats VectivBio on 2 of the 3 factors compared between the two stocks.

How does VectivBio compare to Atlantic Coastal Acquisition Corp. II?

VectivBio (NASDAQ:VECT) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, VectivBio had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Atlantic Coastal Acquisition Corp. II. VectivBio's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

VectivBio beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does VectivBio compare to Biofrontera?

VectivBio (NASDAQ:VECT) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, VectivBio had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Biofrontera. VectivBio's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Biofrontera Neutral

Summary

VectivBio and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

Get VectivBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VECT vs. The Competition

Export
MetricVectivBioMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.41B$6.43B$12.59B
Dividend YieldN/A2.32%2.68%5.81%
P/E RatioN/A19.7324.7524.43
Price / SalesN/A320.08529.99108.89
Price / CashN/A127.8445.0755.09
Price / BookN/A8.1610.806.58
Net IncomeN/A$23.94M$3.57B$337.17M
7 Day PerformanceN/A2.57%0.72%0.83%
1 Month PerformanceN/A0.69%0.41%2.25%
1 Year PerformanceN/A55.09%29.34%36.14%

VectivBio Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
N/A$16.85
flat		N/AN/A$0.00N/AN/A30
AIMDW
Ainos
N/A$0.12
-17.8%		N/A-48.8%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.37
+54.8%		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
-26.5%		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:VECT) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel